Skip to main content

US Stock Future ahead of the Job Data

U.S. stock futures pointed to a slightly lower open on Friday, as markets awaited the release of upcoming U.S. jobs data amid growing uncertainty over the future of the Federal Reserve's stimulus program. 
Ahead of the open, the Dow Jones Industrial Average futures pointed to a 0.11% fall, S&P 500 futures signaled a 0.08% loss, while the Nasdaq 100 futures indicated a 0.07% dip. 
Investors eyed upcoming U.S. jobs data after the Department of Labor on Thursday said the number of people who filed for unemployment assistance last week fell by 11,000 to 346,000, compared to expectations for a decline of 12,000 to 345,000.
Jobless claims for the preceding week were revised up to 357,000 from a previously reported increase of 354,000.
The data came one day after weak U.S. private sector jobs data lowered expectations that the Federal Reserve would begin to unwind its asset purchase program this year. 
The telecom sector was expected to be active, after AT&T said second-quarter TV, Internet and mobile-phone subscriber growth is improving compared with a year earlier. The company added however that the costs to lure customers is cutting into profits. 
AT&T shares were down 0.34% in after-hour trade. 
Tech stocks were also likely to be in focus, as a number of U.S. technology providers including Apple and Yahoo! said they don’t give the U.S. government direct access to their systems, responding to newspaper reports of a top-secret electronic surveillance program. 
The Washington Post and the Guardian reported late Thursday that the National Security Agency and the Federal Bureau of Investigation access the central servers of nine U.S. Internet companies, extracting audio and video chats, photographs, e-mails, documents and connection logs. 
Among pharmaceuticals, GlaxoSmithKline was slated to move after U.S. advisers said the firm's best-selling diabetes pill Avandia may have been overstated and restrictions on prescribing the drug should be eased. 
Across the Atlantic, European stock markets were lower. The EURO STOXX 50 slipped 0.21%, France’s CAC 40 edged down 0.17%, Germany's DAX declined 0.34%, while Britain's FTSE 100 fell 0.14%. 
During the Asian trading session, Hong Kong's Hang Seng Index tumbled 1.05%, while Japan’s Nikkei 225 Index retreated 0.85%. 
Later in the day, the U.S. was to release government data on nonfarm payrolls and the unemployment rate.

Comments

Popular posts from this blog

Wizard of Dalal Street: Govind Parikh's investment mantra

Wizard of Dalal Street: Govind Parikh's investment mantra Govind Parikh of Govind Parikh Securities says selling right is more important than correct buying. He says it is necessary to keep a lot of cash. "We keep an average 10 percent cash in our portfolio," he says I like to buy things in a bad market. Additionally, don't look current cash flow, concentrate on future cash flows — that is what  I look at," says Govind Parikh of Govind Parikh Securities. He advises investors to buy good quality stocks when the market crashes. While sharing his investment philosophy with ace investor Ramesh Damani, on the Wizards of Dalal Street, Parikh says management integrity is very important when deciding which stock to bet on. He tells investors not to buy stocks impulsively. According to him, selling right is more important than correct buying. He says it is necessary to keep a lot of cash. "We keep an average 10 percent cash in our portfolio," he says. He al...

Bank Nifty

Bank Nifty Bank Nifty is a Sell at Current Levels with a Stop Loss of 12,750 Once Below 12,400 the next major Support shall be only 12,000 Levels so a person can go short is bearish or buy putt if moderately bearish . 

Budget 2018: Mega health plan to cost Rs 1 lakh crore

The mega healthcare plan for the poor, as announced in the Budget, will cost about Rs 1,00,000 crore annually and curtail states' autonomy to design their own policies in the sector, says a research paper, authored by a professor at economic think tank NIPFP. The paper's estimate is 10 times higher than the one made last week by Niti Aayog adviser Alok Kumar, who had said that the National Health Protection Scheme (NHPS) will cost around Rs 10,000-12,000 crore annually. National Institute of Public Finance and Policy (NIPFP) Assistant Professor Mita Choudhury said in the paper -- 'The National Health Protection Scheme in the Union  Budget 2018 : Is it in the Right Direction?' -- that resource requirements for implementing NHPS are likely to be very high. Not only would such a scheme impose a heavy burden on both the Union and the states' exchequers, it will also curtail states' autonomy to design their own policies in a sector that is constitutionally ma...